AwardedDNKGoodsFramework agreementDKK 133,000,000
Amgros 2026 1.551.a
- Published
- Published 16 March 2026
- Deadline
- Closed 24 April 2026
Overview
Amgros I/S, a joint venture owned by Denmark's five regions, has awarded framework agreements for pharmaceutical supply to hospitals and regional pharmacies. The contract was awarded on 5 May 2026 to Abacus Medicine A/S, Merck A/S, and Orifarm A/S for a total value of 44.3 million DKK against an estimated budget of 133 million DKK, with non-exclusive arrangements and no mandatory purchasing obligations.
Key details
- Country
- DNK
- Status
- Awarded
- Category
- Goods
- Estimated value
- DKK 133,000,000
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 16 March 2026
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- DKK 44,333,333
- Award date
- 5 May 2026
- Contract period
- 1 November 2026 → 31 October 2028
- Abacus Medicine A/S
- Merck A/S
- Orifarm A/S
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
5 May 2026
Contract Notice
16 March 2026
Contracting authority
Amgros I/S
Procuring entityKøbenhavn Ø, DNK
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.